PMDA Updates
Pharmaceuticals and Medical Devices Safety Information
PMDA Risk Communications
2nd PMDA Medical Devices Training Seminar
  • PMDA Updates
  • Pharmaceuticals and Medical Devices Safety Information
  • PMDA Risk Communications
  • 2nd PMDA Medical Devices Training Seminar
5th PMDA Training Seminar SEMINAR HIGHLIGHT DAY 1 DAY 2 DAY 3 DAY 4 DAY 5
What's NewRSS FeedsBack number
->January 30, 2015 new
PMDA Updates (January, 2015) posted
->January 29, 2015 new
Executive Summary of Pharmaceuticals and Medical Devices Safety Information No 320, FY2014
->January 29, 2015 new
1st Malaysia-Japan Symposium
->January 23, 2015
PMDA Risk Communication: abiraterone, montelukast, telaprevir, memantine, and apixaban posted
->January 23, 2015
MHLW Pharmaceuticals and Medical Devices Safety Information posted: No 318, FY2014
->January 22, 2015
New drugs approvals: April - September 2014
->January 15, 2015
The 2nd Meeting of the Subcommittee on Placebo-controled Studies
->January 9, 2015
Revisions of PRECAUTIONS : mumps virus vaccine, linagliptin, sodium-glucose co-transporter 2 inhibitors, simeprevir, amoxicillin, and levetiracetam posted
->January 9, 2015
Presentation material: package insert notification system
->January 6, 2015
Past Presentation: Files added
Publications: Updated
->December 26, 2014
The 2nd Meeting of the Subcommittee on Evaluation of Medical Devices in Peditric Use
->December 26, 2014
The 2nd Subcommittee on Non-clinical Studies Meeting
->December 26, 2014
PMDA Updates (December, 2014) posted
->December 24, 2014
Executive Summary of Pharmaceuticals and Medical Devices Safety Information No 319, FY2014
->December 22, 2014
Revisions of PRECAUTIONS: cabazitaxel posted
->December 17, 2014
Administrative Notice, Q&A on Adverse Drug Reaction and Malfunction Reports of Combination Products
->December 17, 2014
MHLW Pharmaceuticals and Medical Devices Safety Information posted: No 317, FY2014
->December 16, 2014
Publications: Updated

>> Back number

International Programs

Implementation of PMDA International Strategic Plan through international regulatory harmonization, bilateral relationship, effective communication with relevant external parties, etc.

News and Reports
The Science Board

Framework to explore appropriate methods to evaluate medical products using advanced science and technology while exchanging opinions among academia and reviewers.

The Science Board The Science Board Subcommittees Outcome documents of the Science Board
Events / Symposia
Seminar
Past Presentations
Publications
Frequently Asked Questions (FAQ)
Services of PMDA
Drug and Medical Device Reviews

Scientific reviews and conformity audits of marketing authorization applications of drugs and medical devices, clinical trial consultations

Post-marketing Safety

Collection, analysis and dissemination of information related to the quality, efficacy and safety of pharmaceuticals and medical devices

Relief Services for Adverse Health Effects

Providing financial assistance for individuals affected by adverse drug reactions or infections from biological products